Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Snapinn

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|March 1, 1992
Monitoring clinical trials with a conditional probability stopping ruleS M Snapinn
Statistics in Medicine|September 1, 1987
Evaluating the efficacy of a combination therapyS M Snapinn
Biometrics|May 9, 1998
Survival analysis with uncertain endpointsS M Snapinn
Biometrics|September 1, 1986
Tests of significance using regression models for ordered categorical dataS M Snapinn, R D Small
Journal of Biopharmaceutical Statistics|July 1, 1996
A note on assessing the superiority of a combination drug with a specific alternativeS M Snapinn, S K Sarkar
Biometrics|March 1, 1989
Estimation of error rates in discriminant analysis with selection of variablesS M Snapinn, J D Knoke
Statistics in Medicine|June 11, 1999
A discriminant analysis extension to mixed modelsL Tomasko, R W Helms, S M Snapinn
Journal of Biopharmaceutical Statistics|May 23, 1998
Power considerations when a continuous outcome variable is dichotomizedB A Deyi, A S Kosinski, S M Snapinn
Circulation|October 12, 1999
Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS InvestigatorsX Q Zhao, P Théroux, S M Snapinn, et al.
Circulation Research|July 1, 1980
Inlet and intrachamber concentration distributions in tracer studies of the canine central circulation and their relation to the isotope dilution residue functionF S Castellana, S M Snapinn, S Y Tam, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|March 1, 1992
Monitoring clinical trials with a conditional probability stopping ruleS M Snapinn
Statistics in Medicine|September 1, 1987
Evaluating the efficacy of a combination therapyS M Snapinn
Biometrics|May 9, 1998
Survival analysis with uncertain endpointsS M Snapinn
Biometrics|September 1, 1986
Tests of significance using regression models for ordered categorical dataS M Snapinn, R D Small
Journal of Biopharmaceutical Statistics|July 1, 1996
A note on assessing the superiority of a combination drug with a specific alternativeS M Snapinn, S K Sarkar
Biometrics|March 1, 1989
Estimation of error rates in discriminant analysis with selection of variablesS M Snapinn, J D Knoke
Statistics in Medicine|June 11, 1999
A discriminant analysis extension to mixed modelsL Tomasko, R W Helms, S M Snapinn
Journal of Biopharmaceutical Statistics|May 23, 1998
Power considerations when a continuous outcome variable is dichotomizedB A Deyi, A S Kosinski, S M Snapinn
Circulation|October 12, 1999
Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS InvestigatorsX Q Zhao, P Théroux, S M Snapinn, et al.
Circulation Research|July 1, 1980
Inlet and intrachamber concentration distributions in tracer studies of the canine central circulation and their relation to the isotope dilution residue functionF S Castellana, S M Snapinn, S Y Tam, et al.
Pageof 2